Injectable Drug Delivery: Market Impact and Industry Trends

Table of Contents

1. Executive Summary

2. Introduction to Drug Delivery

• 2.1. Drug Delivery Technologies and Pharmaceutical Revenues
• 2.2. Drug Delivery Technologies and Wider Healthcare Market

3. Overview of Injectable Drug Delivery

• 3.1. Advantages and Disadvantages of Injectable Delivery
• 3.2. Types of Injectable Drug Delivery

4. Main Categories of Marketed Injectable Drug Delivery Systems

• 4.1. Sustained Release Injectable Systems
• 4.2. Advantages of Injectable Sustained-Release Formulations
• 4.3. Liposomal Systems
• 4.4. Advantages of Injectable Liposomal Formulations
• 4.5. Needleless Systems
• 4.6. Advantages of Injectable Needleless Formulations

5. Injectable Drug Delivery Market - Facts and Figures

• 5.1. Injectable Drug Delivery Market Overview
• 5.2. Key Therapeutic Areas for Injectable Drug Delivery
• 5.3. Acromegaly
• 5.4. Age-Related Macular Degeneration
• 5.5. Crohn' s Disease
• 5.6. Diabetes
• 5.7. Hepatitis C
• 5.8. Multiple Sclerosis
• 5.9. Neutropenia
• 5.10. Oncology
• 5.11. Pain
• 5.12. Psoriasis
• 5.13. Rheumatoid Arthritis

6. Drug Classes Appropriate for Injectable Drug Delivery

7. Main Players and Partnerships in the Injectable Drug Delivery Market

8. Key Company Involvement in the Field of Injectable Drug Delivery

• 8.1. Alkermes
• 8.2. ALZA
• 8.3. Aradigm
• 8.4. Bioject
• 8.5. Enzon
• 8.6. Ethypharm
• 8.7. MacroMed
• 8.8. Nektar Therapeutics
• 8.9. QLT
• 8.10. SkyePharma

9. Sales of Products Utilizing Injectable Drug Delivery Technology

10. Profiles of Key Products Using Injectable Drug Delivery Technology

• 10.1. Neulasta (Nektar/Amgen)
• 10.2. PEGASYS (Roche/Nektar)
• 10.3. PEG-Intron (Schering-Plough)
• 10.4. Risperdal Consta
• 10.5. Sandostatin (Novartis)
• 10.6. Vivitrol (Alkermes)

11. Recent Launches and Approvals in the Field of Injectable Drug Delivery

• 11.1. August 2006
• 11.2. July 2006
• 11.3. May 2006
• 11.4. April 2006
• 11.5. February 2006
• 11.6. January 2006

12. Current Research and Profiles of Key Pipeline Products in the Field of Injectable Drug Delivery

• 12.1. Cimzia (Nektar)
• 12.2. Mircera/CERA (Nektar)
• 12.3. Paliperidone Palmitate (Johnson & Johnson)
• 12.4. Intraject Sumatriptan (Zogenix)

13. Future of Injectable Drug Delivery Technology

• 13.1. Emerging Injectable Drug Delivery Technologies
• 13.2. Emerging Therapeutic Targets for Injectable Drug Delivery
• 13.3. Future Therapeutic Targets for Injectable Drug Delivery
• 13.4. New Technology and the Injectable Drug Delivery Market
• 13.5. New Threats to the Injectable Drug Delivery Market
• 13.6. New Healthcare Needs and the Injectable Drug Delivery

14. Outlook for Injectable Drug Delivery Technology